| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 12 Apr 2023 Last Split | - IPO Date |
Nexturn Bioscience Co., Ltd. stands out as a leading figure within the biotechnology industry, with a primary focus on the development and production of cutting-edge biopharmaceutical products. The firm is renowned for its expertise in the research and manufacturing of pharmaceutical ingredients critical for groundbreaking therapeutic solutions. Nexturn Bioscience's operations are pivotal in generating active compounds essential for various medical treatments, thereby playing an instrumental role in the advancement of healthcare. As an integral component of the pharmaceutical supply chain, the company supports a wide range of clientele, from small biotech startups to large-scale pharmaceutical corporations. Through its dedication to rigorous R&D efforts, Nexturn Bioscience is at the forefront of discovering and refining life-saving drugs and therapies, solidifying its status as a cornerstone in the pursuit of medical progress.
Nexturn Bioscience is deeply involved in the development of biopharmaceutical products that target various diseases and conditions. This involves intricate processes of bioengineering, clinical research, and drug formulation to create effective and safe therapeutic options. Their work in this area aims to bridge the gap between scientific discovery and the availability of new treatments in the market, thus addressing unmet healthcare needs.
The company excels in the manufacturing of pharmaceutical ingredients, which are crucial for the production of medications. This service encompasses the synthesis, refinement, and commercial production of active pharmaceutical ingredients (APIs) and other critical components required for drug development. Nexturn Bioscience employs state-of-the-art technology and strict quality control measures to ensure that these ingredients meet the highest standards of purity and efficacy.
Nexturn Bioscience's R&D initiatives are fundamental to its mission, driving innovation in the biopharmaceutical field. The company invests significantly in research activities to explore new therapeutic areas, improve existing treatment modalities, and develop pioneering drug delivery systems. These efforts contribute to the scientific community's collective understanding and open new avenues for treating diverse medical conditions.